Medtronic
This article was originally published in The Gray Sheet
Executive Summary
Rolls out in Europe and Canada silicone and polyurethane models of its CapSure SP Novus bradycardia pacemaker leads for atrial and ventricular pacing, the firm reports in a May 21 release. The latest addition to the CapSure SP family of lead products, the Novus series offers a "smaller diameter lead body because of new proprietary silicone insulation." The polyurethane models provide "the handling and size advantages preferred by many physicians while their inner silicone insulation provides flexibility," Medtronic explains. The firm also introduces in Europe, Canada and Australia the Analyzer external testing device for pacing lead assessment during pacemaker or defibrillator implantation or lead system "troubleshooting." The system is incorporated into the Medtronic desk programmer, Model 9790, and replaces the firm's model 5311 (B) lead assessment device
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.